Cardiovascular disease prevention, blood pressure, cholesterol, and heart function
617 articles
Large randomized trial tests whether deferring coronary stents during TAVI procedures is safe and effective for heart patients.
Decade-long trial reveals new insights on post-stent medication strategies beyond traditional aspirin therapy.
Women experiencing early menopause face significantly higher cardiovascular disease risk, according to new research published in JAMA.
Global study of 2+ million people reveals how hypertension, diabetes, smoking, obesity and high cholesterol dramatically reduce lifespan.
New composite index combining triglyceride-glucose levels with frailty scores dramatically improves cardiovascular risk prediction in older adults.
AI analysis of 282 patients reveals specific inflammatory markers that can predict coronary heart disease risk in people with fatty liver disease.
New trial shows home cardiac rehab with smartwatch monitoring equals traditional center-based programs for heart failure patients.
FAME 3 trial finds no difference in death, stroke, or heart attack rates between bypass surgery and stents at 5 years, though stents had more complications.
Machine learning model identifies HFpEF patients 6.3 years before symptom onset with 93% accuracy using integrated clinical and molecular data.
Natural isoflavone prevents cardiac enlargement through novel mitochondrial protection pathway, offering new therapeutic approach.
Breakthrough study shows one epigenetic factor can transform cardiac fibroblasts into heart muscle cells, improving function after myocardial infarction.
New research questions whether intravascular ultrasound is always necessary for evaluating left main coronary artery disease.
